State Of Alaska, Department Of Revenue Enanta Pharmaceuticals Inc Transaction History

State Of Alaska, Department Of Revenue

$9.42 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	SELL	$20.68 - $39.85 $8,830 - $17,015	-427 Reduced 3.18%	13,017 $278,000
Q1 2023 Apr 17, 2023	SELL	$38.82 - $54.59 $4,813 - $6,769	-124 Reduced 0.91%	13,444 $543,000
Q4 2022 Jan 11, 2023	BUY	$40.77 - $53.73 $3,261 - $4,298	80 Added 0.59%	13,568 $631,000
Q3 2022 Oct 20, 2022	SELL	$48.29 - $71.27 $22,068 - $32,570	-457 Reduced 3.28%	13,488 $699,000
Q2 2022 Jul 08, 2022	BUY	$38.13 - $76.93 $47,662 - $96,162	1,250 Added 9.85%	13,945 $659,000
Q1 2022 Apr 14, 2022	SELL	$56.06 - $74.11 $2,522 - $3,334	-45 Reduced 0.35%	12,695 $903,000
Q4 2021 Jan 12, 2022	SELL	$60.19 - $97.37 $23,173 - $37,487	-385 Reduced 2.93%	12,740 $952,000
Q3 2021 Oct 07, 2021	BUY	$41.02 - $58.65 $28,303 - $40,468	690 Added 5.55%	13,125 $745,000
Q2 2021 Jul 12, 2021	BUY	$43.76 - $53.11 $12,340 - $14,977	282 Added 2.32%	12,435 $547,000
Q1 2021 Apr 09, 2021	SELL	$41.69 - $54.95 $72,957 - $96,162	-1,750 Reduced 12.59%	12,153 $599,000
Q4 2020 Jan 08, 2021	SELL	$41.16 - $47.47 $115,247 - $132,916	-2,800 Reduced 16.76%	13,903 $585,000
Q3 2020 Oct 05, 2020	BUY	$43.36 - $53.53 $61,571 - $76,012	1,420 Added 9.29%	16,703 $764,000
Q2 2020 Jul 06, 2020	BUY	$46.37 - $57.58 $21,330 - $26,486	460 Added 3.1%	15,283 $767,000
Q1 2020 Apr 06, 2020	BUY	$40.22 - $62.0 $110,806 - $170,810	2,755 Added 22.83%	14,823 $762,000
Q4 2019 Jan 07, 2020	SELL	$57.95 - $66.61 $10,488 - $12,056	-181 Reduced 1.48%	12,068 $745,000
Q3 2019 Oct 02, 2019	BUY	$60.08 - $88.17 $410,166 - $601,936	6,827 Added 125.91%	12,249 $735,000
Q2 2019 Jul 23, 2019	BUY	$81.3 - $97.35 $9,349 - $11,195	115 Added 2.17%	5,422 $457,000
Q1 2019 Apr 09, 2019	BUY	$69.08 - $105.66 $1,727 - $2,641	25 Added 0.47%	5,307 $506,000
Q4 2018 Jan 10, 2019	BUY	$65.41 - $84.65 $13,082 - $16,930	200 Added 3.94%	5,282 $374,000
Q3 2018 Oct 09, 2018	BUY	$85.46 - $126.37 $30,081 - $44,482	352 Added 7.44%	5,082 $434,000
Q2 2018 Jul 10, 2018	BUY	$81.85 - $120.51 $7,366 - $10,845	90 Added 1.94%	4,730 $548,000
Q1 2018 Apr 19, 2018	BUY	$57.91 - $92.15 $104,238 - $165,870	1,800 Added 63.38%	4,640 $375,000
Q4 2017 Jan 19, 2018	BUY	$45.65 - $59.37 $4,108 - $5,343	90 Added 3.27%	2,840 $166,000
Q3 2017 Oct 16, 2017	BUY	$37.91 - $46.8 $104,252 - $128,699	2,750	2,750 $128,000

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$19.7 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$18.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$17.3 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$14 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.1M
Shares

$10.3 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.

Account